Henry Schein Inc. closed 6.05% short of its 52-week high of $82.63, which the company achieved on February 27th.

Fintel reports that on February 14, 2025, Wells Fargo initiated coverage of Henry Schein (NasdaqGS:HSIC) with a Equal-Weight ...

Henry Schein Medical, the U.S. medical business of Henry Schein, Inc. (Nasdaq: HSIC), is paying tribute to women athletic ...

Henry Schein Inc. closed 8.02% below its 52-week high of $82.63, which the company reached on February 27th.

MELVILLE, N.Y., February 12, 2025--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC) announced today that Stanley M. Bergman, Chairman of the Board and Chief Executive Officer, received the ...

NEW YORK, Jan 22 (Reuters) - Activist investor Ananym Capital Management plans to nominate as many as half a dozen directors to the board at Henry Schein (HSIC.O), opens new tab, arguing the ...

NEW YORK (Reuters) - Activist investor Ananym Capital Management plans to nominate as many as half a dozen directors to the board at Henry Schein, arguing the dental and medical distributor needs ...

MELVILLE, N.Y.--(BUSINESS WIRE)-- Henry Schein, Inc. (Nasdaq: HSIC) (“Henry Schein” or the “Company”), the world’s largest provider of health care solutions to office-based dental and ...

(Reuters) -Private equity firm KKR has taken a large stake in Henry Schein and reached a deal to add members to the company's board, the distributor of medical products said on Wednesday. Shares of ...

Securities updated their financial outlook on Henry Schein (NASDAQ:HSIC), increasing the price target to $78 from the previous $75, while maintaining a Neutral rating on the company's stock. According ...